OneNeb

A quick spec on Ingeniatrics latest achievements

Ingeniatrics briefly presented its technological advances, expanding product portfolio in market and increase solutions in customer needs by the new facilities' scalability in order to produce and manufacture microparticles.


For further information click here

Aliter journal: Biotechnology and business

Aliter published the fourth edition of the journal "Biotechnology and Business."  This publication aims to connect companies, government agencies, authorities, investors and universities.

In this issue we could find several interest biotechnology topics, such as interviews with sector business leaders, successful managers as  Joaquin Gomez Moya, CEO of Ingeniatrics, as well as international studies.

For further information click here

Revista de la APD, Asociación para el Progreso de la Dirección: "De la Ciencia al Mercado. Lo que los fracasos enseñan". Joaquín Gómez Moya.

Para quienes dirigimos empresas tecnológicas con un fuerte componente de I+D y cercanas a la Universidad, basta comparar un currículum académico, exhaustivo en su información, con uno ejecutivo, que sintetiza lo relevante en un folio mejor que en dos, para percibir la distancia oceánica entre las mentes del investigador y del directivo de empresa. Quiero compartir con ustedes lo aprendido en el transcurso de mi carrera, mi currículum.

Para leer el resto del artículo pinche aqui

La US y la empresa Ingeniatrics refuerzan sus lazos de colaboración tecnológica

El convenio proporciona a la empresa asesoramiento científico en tecnología microfluídica por parte de investigadores de la US y cede la licencia de explotación de las patentes registradas por esta institución que hayan surgido como resultado del trabajo conjunto.

Para más información pinche aqui

Frost & Sullivan awards it '2011 European Micro-Encapsulation Technology Innovation Award' to Ingeniatrics Tecnologías

Further information click here

Ingeniatrics' Directors Board appoints new auditor and new attorney: BDO and KPMG.

Ingeniatrics Tecnologias Board of Directors will propose its next Stakeholder Assembly BDO as auditor of the company. Furthermore, KPMG has been hired as legal advisor in the role of Secretary of the Board.  

With these two moves, Ingeniatrics Tecnologias reinforces its frame of collaborations and partnerships with a view to develop its ambitious expansion plan in the company of "the best ones", as they put it.

According to this vision, if Ingeniatrics aims to get a relevant position amongst world leaders in microencapsulation manufacturing industry they should face this challenge utilizing the best professional services available. BDO and KPMG are amongst the world most relevant companies in their respective fields of expertise with presence in Seville.

Manuel Rodriguez, Invercaria's representative in the Board.

Manuel Rodriguez a seasoned professional in auditory and financial management is going to represent Invercaria in the new Board.

Ingeniatrics' CEO, Joaquin Gomez Moya says:

"When it came to found our Joint Venture in the USA we made a consult to Backer & McKensey's office at New York City. In a similar way, when we needed to review some licensing agreements we passed them to Elzaburu's team in Madrid. Our international marketing planning has been developed with Hervé de Troostemberg. Lately we've hired our Account Manager through Dopp.

You can see a pattern here. As you can see in the investors we chose: Caixa and Invercaria who are contributing their huge experience at technological companies management. To get to a position of leadership you have to go there in the company of the leaders. Their contribution is a continuous source of learning and inspiration."

Ingeniatrics Tecnologias, Microencapsulation for you.

Ingeniatrics Tecnologias is currently building the new facilities to manufacture microencapsulated production for Pharma, Biotech, Nutrition and Chemistry at Parque Plata, Camas, Seville. At the same time it has launched a range of products for prosthesis coating, for bioencapsulation applied to cell therapy research and microbiology, and for diagnosis. To convey this mission they have tagged their name with the claim "Microencapsulation for you"